3Sunaga Y, Gonoi T, Shibasaki T, et al. The effects of mitiglinide(KAD- 1229), a new anti - diabetic drug, on ATP- sensitive K^+ channels andinsulin secretion: comparison with the sulfonylureas and nateglinide. Eur J Pharmacol 2001; 431:119-125.
4Uto Y, Teno S, Iwamoto Y, et al. Improvement of glucose tolerance by nateglinide occurs through enhancement of early phase insulin secretion. Metabolism 2002 ; 51 : 20- 24.
5Bando K. Yamada Y. Glimepiride(Amaryl): a review of its pharmacological and clinical profile. Nippon Yakurigaku Zasshi 2001 ; 118:59-67.
6Chilcott J, Tappenden P, Jones ML, et al. A systematic review of the clnical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus. Clin Ther 2001 ; 23 : 1792-1823.
7Gokcel A, Karakose H, Ertorer EM, et al, Effects of sibutramine in obese female subjects with type 2 diabetes and poor blood glucose control. Diabetes Care 2001 ; 24 : 1957 - 1960.
8Sels JP, Huijerts MS, Wolffenbuttel BH. Miglitol, a new alpha - glucosidase inhibior. Expert Opin Pharmacother 1999;1:149-156.
10Blazar BR et al. In vivo chloroquine - induced inhibition of insulin degradation in a diabetic patient with severe insulin resistance. Diabetes 1984 ; 33 : 1133.
二级参考文献36
11，Fuhlendorff J,Rorsman P,Kofod H et al.Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinet processes.Diabetes,1998;47(3):345
22，Owens DR.repaglinide-prandial glucose regulator:a new class of oral antidiabetic drugs.Diabet Med,1998;15suppl(4):S28
33，John R,White Jr,Pharm D.The pharmacological reduction of blood glucose in patients with type 2 diabetes melitus.Clinical Diabetes,1998;16:2
44 Polonsky KS,Sturis J,Bell CI.Seminars in Medicine of the Beth Israel Hospital,Boston.Non-insulin-dependent diabetes melitus-a genetically programmed failure of the beta cell to compensate for insulin resistance.N Engl J Med,1996;334(12):777
55，P J Lefebvre,Scheen AJ.The postprandial state risk of cardiovascular disease.Diabet Med,1998;15(Suppl 4):S63
66，Goldberg,Einhorn D,Lucas CP,et al.A randomized placebocontrolled trial of repaglinide in the teatment of type 2 diabetes.Diabetes Care,1998;21(11):1897
77，Landgraf R,Bilo HJ.A comparison of repaglinide and glibenclamide in the treatment of type 2 diabetic patients previously treated with sulphonylureas.1999;55(3):165
88，Wolffenbuttel BH,LandgrafR.A 1-year multicenter randomized double-blind comparison of repaglinide and glyburide for the treatment of type 2 diabetes.Dutch and German repaglinide Study Group Diabetes Care,1999;22(3):463
